The use of low dose Tolvaptan in the treatment of refractory SIADH in small cell lung cancer

被引：0
|
作者：
Ryan, D. [1 ]
Casey, R. [1 ]
Blazcova, S. [2 ]
O'Shea, P. [3 ]
Bell, M. [1 ]
机构：
[1] Univ Hosp Galway, Dept Endocrinol, Galway, Ireland
[2] Univ Hosp Galway, Dept Oncol, Galway, Ireland
[3] Univ Hosp Galway, Dept Clin Biochem, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P52
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [1] Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan
    Schnaiter, A.
    Hiddemann, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (41) : 2077 - 2079
  • [2] SIADH Escape or Tolvaptan Resistance in Progressive Small Cell Lung Cancer
    Mandal, Sunny
    Kannan, Lakshmi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 736 - 736
  • [3] Hyponatraemia secondary to SIADH in small cell lung cancer treated with tolvaptan
    Pothina, N. P.
    Mohammed, K.
    LUNG CANCER, 2013, 79 : S66 - S66
  • [4] A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
    Claudia Petereit
    Okan Zaba
    Ishak Teber
    Heike Lüders
    Christian Grohé
    BMC Pulmonary Medicine, 13
  • [5] A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan
    Petereit, Claudia
    Zaba, Okan
    Teber, Ishak
    Lueders, Heike
    Grohe, Christian
    BMC PULMONARY MEDICINE, 2013, 13
  • [6] Tolvaptan use in a patient with metastatic small cell lung cancer
    Mumby, C.
    Adam, S.
    LUNG CANCER, 2012, 75 : S59 - S60
  • [7] Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH)
    Harbeck, Birgit
    Lindner, Ulrich
    Haas, Christian S.
    ENDOCRINE, 2016, 53 (03) : 872 - 873
  • [8] The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases
    Ren, Peng
    Yang, Qiuan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1229 - 1237
  • [9] Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH)
    Birgit Harbeck
    Ulrich Lindner
    Christian S. Haas
    Endocrine, 2016, 53 : 872 - 873
  • [10] Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) - a case series
    Fraser, I. M.
    Brooke, A. M.
    Dorey, N. E.
    Toy, E. W.
    LUNG CANCER, 2014, 83 : S69 - S69
12345